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AbsTrACT
Objective To investigate the feasibility of determining 
the pattern and prevalence of alcohol consumption 
in pregnancy by measuring ethanol biomarkers in 
meconium.
Design Population-based observational study.
setting Inner-city maternity unit in Scotland, UK.
Population Random sample of singleton infants 
delivered after 36 completed weeks’ gestation.
Methods Fatty acid ethyl esters (FAEEs) and ethyl 
glucuronide (EtG) in meconium were measured by liquid 
chromatography-mass spectroscopy. Samples were 
frozen at −20°C before analysis. Results were compared 
anonymously with demographic data including maternal 
age, parity, smoking, ethnicity and postcode and with 
infant gestation, birth weight and head circumference. 
Written informed consent was obtained from all subjects.
results 235 samples of meconium were analysed (70% 
of eligible babies). Only four (1%) of mothers declined 
to participate. FAAEs were detected in all, including four 
samples below the limit of quantification (10 ng/g). 98 
(42%) samples had FAEE concentrations >600 ng/g. EtG 
was detectable in 93 (40%) samples; in 35 (15%) EtG 
concentration was >30 ng/g. No mother reported heavy 
alcohol consumption in pregnancy. FAAE concentration 
correlated with EtG (Pearson’s coefficient; p<0.001). 
There was no association between either biomarker and 
maternal age, parity, smoking, ethnicity or postcode, or 
infant gestation, birth weight or head circumference.
Conclusion Measurement of ethanol biomarkers in 
meconium is a feasible tool for determining the pattern 
and prevalence of alcohol consumption in pregnancy. 
Data suggest that at least 15% of pregnant women in 
the west of Scotland are consuming significant quantities 
of alcohol during latter pregnancy.
InTrODuCTIOn
The effects of excess alcohol consumption are 
estimated to cost the National Health Service in 
England and Wales >£3.5 billion per year with a 
total annual cost to society of around £21 billion.1 
In Scotland, although alcohol use has been falling 
over the past decade, the majority of women drink 
alcohol, with 60%–70% of women aged 16–44 
classified as moderate drinkers (consuming up 
to 14 units per week) and 13%–24% of women 
drinking hazardously (>14 units per week).2 Data 
suggest that hazardous alcohol consumption is 
most common in women in highest income house-
holds compared with those in the lowest income 
households (22% vs 13%).2 3 Ethanol is teratogenic 
and the current UK government recommendations 
are for complete abstinence from alcohol consump-
tion during pregnancy.4 Despite this advice, some 
women drink heavily before they realise they are 
pregnant, and others continue to drink through 
their pregnancy.5 Prenatal alcohol exposure (PAE) 
may lead to miscarriage, premature birth and 
increased perinatal morbidity and mortality.6 7Fetal 
alcohol spectrum disorder (FASD) describes a 
continuum of difficulties with learning, develop-
ment, attention, social relationships and impulsive 
behaviour. At the severe end of the spectrum, fetal 
alcohol syndrome (FAS) is characterised by intra-
uterine growth restriction, reduced head circum-
ference with poor postnatal growth, and typical 
craniofacial features.6 7 Based on a recent American 
study, up to 5% of school-age children in the USA 
and Western Europe may be affected by FAS/FASD.8 
Since pregnant women commonly under-report 
alcohol use in pregnancy,9 10 and direct measure-
ment of alcohol metabolites in the mother is diffi-
cult due to rapid metabolism of alcohol, the exact 
prevalence of FAS/FASD in the UK is unknown.
An alternative to self-reporting of alcohol 
consumption is the measurement of ethanol 
biomarkers in meconium.11–17 Ethyl glucuronide 
(EtG) is formed in the mother from conjugation 
of ethanol with glucuronic acid, which crosses 
What is already known on this topic?
 ► Alcohol use in pregnancy is commonly under-
reported and direct measurement of alcohol 
metabolites in mothers is difficult due to its 
rapid metabolism.
 ► Biomarkers of alcohol can be measured in 
meconium to assess continuing alcohol use in 
pregnancy.
What this study adds?
 ► Confirms under-reporting of alcohol use in 
pregnancy.
 ► Measurement of ethanol biomarkers in 
meconium is a feasible tool for determining the 
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the placenta and is deposited in meconium.12 Ethanol that has 
directly crossed the placenta is metabolised by the fetal liver to 
fatty acid ethyl esters (FAEEs).11 Since meconium begins to be 
formed from 12 to 20 weeks gestation when fetal swallowing of 
the amniotic fluid begins,11 postnatal measurement of ethanol 
biomarkers in meconium reflects PAE over several months prior 
to delivery. FAEE measurement in meconium may be 5–9 times 
more sensitive than self-reported alcohol consumption.18
Small amounts of FAEEs are produced endogenously from 
gut microflora, but concentrations>600 ng/g in meconium 
have been related to regular alcohol consumption during preg-
nancy of >2 drinks per day or binge drinking of >5 drinks per 
occasion.15 Concentrations of EtG >30 ng/g in meconium have 
relatively high sensitivity and specificity for regular alcohol 
consumption in pregnancy.12 Measurement of these biomarkers 
in meconium has the potential to provide more accurate data 
on alcohol consumption during pregnancy than maternal self-re-
porting. Such data are essential for targeting and subsequently 
evaluating interventions aimed at reducing alcohol consumption 
during pregnancy.
To date few data have been published regarding the demo-
graphic associations of excess alcohol consumption during 
pregnancy within geographical areas. In this study, we aimed 
to assess the feasibility of FAEE and EtG measurement in 
meconium as an estimate of alcohol consumption in preg-
nancy in an unselected population, and to explore relation-
ships between these biomarkers and demographic factors 
including maternal age, parity, smoking, ethnicity and socio-
economic status, as well as infant birth weight and head 
circumference.
MeThODs
This observational study was carried out at the Princess Royal 
Maternity (PRM) in Glasgow, Scotland, over a 6-month 
period. The PRM serves the inner-city and northern and 
eastern suburbs of Glasgow, with an average of 6000 births 
annually. All mothers delivering singleton infants born after 
36 completed weeks’ gestation, during every eighth 24-hour 
period over 5 months, were eligible for inclusion. Multiple 
births were excluded.
Meconium collection and analysis
Immediately after birth all eligible mothers were supplied with 
a disposable plastic bag and asked to retain their infant’s first 
meconium for analysis. Samples of meconium were collected 
into anonymised, sequentially numbered containers. Where 
possible the first meconium sample was collected, but the 
second sample was accepted if the first had been missed.
Since FAEEs are unstable at room temperature, samples were 
frozen at −20°C and transported on dry ice to the University 
of Firenze and Padova in Italy for analysis. A fully validated 
method was used for the determination of four FAEEs (ethyl 
myristate, ethyl palmitate, ethyl oleate and ethyl stearate) 
and EtG by liquid chromatography-tandem mass spectrom-
etry.19 To summarise, 200 mg of meconium was sonicated 
for 15 min in the presence of 20 ng of EtG-d5 and 200 ng of 
each FAEE-d5. The supernatant was added to an aminopropyl 
solid-phase extraction cartridge, preconditioned with 2 mL of 
methanol, water and acetonitrile (ACN). FAEEs were eluted 
with 2 mL of hexane and EtG elution carried out with 2 mL 
of water. The two mixtures were dried under nitrogen stream 
and recovered with 50 µL of ACN (FAEE) and 50 µL of meth-
anol (EtG). FAEEs were detected following separation using 
a C8 reversed-phase column. A C18 reversed-phase column 
was used in isocratic mode (1% ACN) for EtG detection. 
Acquisition was in multiple reaction monitoring for all of 
the analytes, in positive mode for FAEEs and negative mode 
for EtG. Lower limit of quantification (LLOQ) values were 
10–15 ng/g for FAEEs and 10 ng/g for EtG.
Demographic information
All mothers were approached by one of two researchers 
shortly after delivery and asked to complete a short informal 
questionnaire regarding their alcohol consumption during 
pregnancy. The questionnaire enquired with regards to quan-
tity (number of units) and frequency of alcohol intake during 
their pregnancy. Patient records were consulted for demo-
graphic information regarding maternal age, parity, ethnicity, 
smoking status, postcode, gestation, birth weight and occipital 
frontal head circumference, which were recorded onto anony-
mised numbered datasheets matched in number to the corre-
sponding meconium sample. Maternal postcode of residence 
was used to derive a DEPCAT. This is a score ranging from 
1 to 7 assigned to every postcode area within Scotland that 
reflects socioeconomic status, with 1 being the most affluent 
and 7 the most deprived.20
resulTs
study population
In total, 329 infants were born during the study period. Written 
consent was obtained from 325mothers. In three of the four 
non-consenting cases, informed consent was not sought due 
to maternal lack of fluency in English and unavailability of an 
interpreter. Only one mother actively declined to participate 
in the study (figure 1). Ninety meconium samples were not 
collected from babies whose mothers had consented either due 
to the meconium sample inadvertently being discarded or due 
to discharge of the mother and infant prior to passage of meco-
nium. The eligible subjects from whom a meconium sample was 
not obtained did not differ in any way, with regard to maternal 
or infant characteristics from those mothers and babies who did 
participate in the study. In total, 235(70% of eligible infants) 
samples were available for analysis, all of which were collected 
within 48 hours of birth and were of sufficient quantity and 
quality to be processed.
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Table 1 shows the demographics of the population studied. 
Almost 50% of participants had a DEPCAT score of 6 or 7 and 
only 8% of the study population resided in the most affluent 
postcode areas (figure 2). Six mothers self-reported alcohol 
consumption during pregnancy, quantified as ‘light social 
drinking only’. No mother reported consuming large amounts of 
alcohol during pregnancy. The six mothers who declared some 
alcohol consumption were of varying age, parity and DEPCAT 
score.
ethanol biomarker levels
FAEEs were detected in 100% of the samples. Four (2%) samples 
had a total concentration of FAEEs below the LLOQ. Ninety-eight 
(42%) of samples had concentrations of FAEES >600 ng/g. EtG 
was detected in 93 (40%) of samples, of which 23 samples had 
EtG concentrations less than the LLOQ. Thirty-five samples 
(15% of all samples) had EtG concentrations>30 ng/g.
There was correlation between the concentrations of FAEEs 
and EtG (Pearson 0.327; p<0.001) (figure 3).
Demographic associations with elevated biomarker levels
There was no significant association between either FAEE or EtG 
and any maternal or infant demographic factors (tables 2 and 3). 
There was a tendency towards a higher proportion of elevated 
FAEE in more affluent women, but the total number of women 
in these groups was low, and the differences were not significant 
(p=0.07, Mann-Whitney test). Infants born in February were 
more likely to have FAEE concentrations>600 ng/g (p<0.05, 
χ2), but were not more likely to have elevated EtG concentra-
tions in meconium.
DIsCussIOn
This pilot study demonstrates the feasibility of collecting anony-
mised meconium samples for population studies of alcohol 
consumption in pregnancy. Only one mother actively declined 
to participate in the study, although it is possible that some of 
the missing samples reflected tacit reluctance to participate. The 
study was generally favourably reviewed by midwifery staff who 
greatly facilitated sample collection.
As well as reflecting alcohol consumption, FAEEs may orig-
inate from endogenous ethanol production or from ethanol 
traces contained in common foods.17 This would explain the 
fact that traces of FAEEs were found in all meconium specimens 
analysed. A cut-off concentration of >600 ng/g in meconium is 
commonly used to indicate alcohol exposure and has been vali-
dated in populations with documented heavy alcohol consump-
tion.16 A recent systematic review of alcohol biomarkers by 
McQuire et al has shown that using a cut-off of 600 ng FAEEs 
per gram of meconium has a high sensitivity (82%–100%) for 
detection of significant alcohol consumption in pregnancy but a 
variable specificity (13%–98%).21 Assuming that self-reporting 
in a known alcohol consuming population is accurate, this 
Table 1 Demographic data of population studied
Factor
Maternal age (years) 29.9 (5.0)
Primiparous mother, n (%) 102 (43)
White British, n (%) 208 (89)
Smoker, n (%) 45 (19)
DEPCAT score (median (IQR)) 6.0 (4–7)
Gestation 39.7 (1.3)
Body weight (kg) 3.46 (0.5)
Occipital frontal head circumference (cm) 34.7 (1.5)
Mode of delivery SVD (Spontaneous vertex delivery), n (%) 119 (50)
Admitted to consumption of alcohol in pregnancy, n (%) 6 (3)
All data mean (SD) unless otherwise stated.
Figure 2 Number of study participants for each DEPCAT score.
Figure 3 Fatty acid ethyl ester (FAEE) versus ethyl glucuronide (EtG) 
concentrations.







Maternal age (years) 30.2 (4.8) 29.6 (5.3) 0.33*
Primiparous mother, n (%) 55 (40.1) 47 (48.0)  0.73†
White British, n (%) 124 (91) 84 (86) 0.67†
Smoker, n (%) 17 (12.4) 23 (23.5) 0.32‡
DEPCAT score
(median (IQR))
6.0 (4–7) 6.0 (4–7) 0.07
Female 75 (54.7) 49 (50) 0.59‡
Birth weight (kg) 3.46 (0.5) 3.46 (0.5) 0.90*
Occipital frontal head 
circumference (cm)
34.7 (1.5) 34.7 (1.5) 0.83*
SVD, n (%) 70 (51.1) 49 (55) 0.92†
Day of delivery 0.39†
Month of delivery 
February
13 (11.7) 29 (24.8) 0.02†
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translates to a positive predictive value of 55%. The percentage 
of tests with FAEE concentrations >600 ng/g (42%) in our study 
is among the highest reported in the literature, but comparable 
with two larger studies from Spain16 and Uruguay.22 Although 
total FAEE concentration was higher among Spanish women who 
used illicit substances including opioids, cocaine and cannabis, in 
Garcia-Algar et al’s study the proportion of samples with FAEE 
concentrations >600 ng/g was 45% regardless of concomitant 
illicit drug use. The subjects in the latter study were described 
as ‘low socioeconomic status’16 consistent with our population 
who had a median DEPCAT score of 6.5 8 Hutson et al’s study 
included a group of women with an 84% unemployment rate 
and also found FAEE concentrations >600 ng/g in 44% of meco-
nium samples.22 The incidence of raised FAEE concentration 
in our study was considerably higher than results from studies 
from Germany (cut-off 500 ng/g), Canada (cut-off 600 ng/g) and 
Italy (cut-off 600 ng/g) which reported raised FAEE concentra-
tions in 7.1%, 3.5% and 7.9% of samples, respectively.11 13 23 
FAEE concentrations may be falsely raised if meconium sample 
collection is delayed or not frozen immediately after collection, 
with a median time of 59 hours for the appearance of FAEEs in 
meconium if the sample is left at room temperature for ≥12 
hours or is refrigerated rather than frozen.11 24 In our study, 
even if we were not able to collect the first meconium sample, 
all samples were collected within 48 hours of birth and were 
rapidly frozen at −20°C, so this is an unlikely explanation for 
our FAEE results. Consumption of olive oil has been described 
as contributing to FAEEs in meconium,16 but this is an unlikely 
contribution to elevated FAEE concentrations in meconium for 
the majority of babies born in the west of Scotland. In a previous 
study from our group, 47% of meconium samples from opioid 
dependent mothers had FAEE concentrations >10 000 ng/g.18 
Only one sample in the current study had concentrations of 
FAEEs >10 000 ng/g, suggesting that extremely high alcohol 
consumption in pregnancy may be confined to particular groups 
of vulnerable women.
Since EtG is only produced from ethanol metabolism, it is 
likely to be a more accurate biomarker of alcohol consump-
tion.13 23 The prevalence of raised EtG in our study was compa-
rable to that reported by Bakdash et al, who reported meconium 
EtG concentrations >30 ng/g in 16.3% of cases in a maternal 
health evaluation study.13 The 3% of women who admitted to 
consuming alcohol during pregnancy in our study is similar to 
the 1% who declared alcohol consumption in Bakdash et al’s 
study. If a positive predictive value of 55% is assumed for FAEE 
concentration >600 ng/g, both alcohol biomarkers are reason-
ably consistent and suggest a prevalence of significant alcohol 
consumption in pregnancy in the west of Scotland of the order 
of 15%–25%.
This study found no significant associations between raised 
ethanol biomarkers in meconium and maternal age, parity, 
ethnicity or smoking status. Alcohol consumption in preg-
nancy is commonly assumed to be associated with poverty, but 
there are no published data to confirm this,The Scottish Health 
Survey 2014 reported a greater likelihood of alcohol consump-
tion during pregnancy in women from higher social classes with 
higher incomes and who shared their home with a partner.2 In 
our study, babies of mothers living in more affluent areas were 
more likely to have FAEE concentrations>600 ng/g but this 
difference was not significant, perhaps reflective of small study 
numbers.
Mothers of infants with concentrations of FAEEs of >600 ng/g 
were more likely to have smoked in pregnancy, but the difference 
was not significant. Co-dependency on nicotine and alcohol is 
well documented and likely to be multifactorial,25 so this may 
well be a true finding, limited by small study numbers.
One of the strengths of this study is its generalisability. By 
seeking to recruit all babies born in every 24-hour period, every 
eighth day, we identified a random cohort. We specifically did 
not target women with a known history of drinking in preg-
nancy. Limitations of this study include relatively small numbers, 
particularly in some demographic groups. Since meconium is not 
a routinely collected substance, we were bound by the terms of 
our Ethics Committee to obtain informed consent from mothers 
to retain their infant’s meconium. Despite the anonymous nature 
of the study, it is possible that some mothers who had consumed 
alcohol throughout pregnancy consented to the study but chose 
not to provide a sample of their infant’s meconium and reported 
this as accidentally discarded. If this was indeed the case, the 
study would tend to underestimate the incidence of alcohol 
consumption in pregnancy. Seventy-five per cent of meconium 
is formed during the last eight weeks of pregnancy,13 17 therefore 
measurement of biomarkers mostly reflects alcohol consumption 
in the third trimester and may miss a proportion of women who 
cease drinking during the course of the pregnancy.
COnClusIOn
This study confirms that women in the west of Scotland under-re-
port their alcohol consumption during pregnancy. Analysis of 
FAEE and EtG in meconium is a feasible and acceptable tool for 
estimating alcohol consumption patterns in pregnancy.
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Maternal age (years) 30.0 (4.9) 29.6 (5.3) 0.68*
Primiparous mother, n (%) 89 (44.5) 13 (37.1) 0.57†
White British, n (%) 178 (89.4) 30 (85.7) 0.79†
Smoker, n (%) 38 (19) 7 (20.0) 0.99‡
DEPCAT score
(median (IQR))
6.0 (4–7) 6.0 (4–7) 0.58
Female, n (%) 106 (53) 19 (54) 1.0‡
Birth weight (kg) 3.46 (0.5) 3.48 (0.5) 0.80*
Occipital frontal head 
circumference (cm)
34.7 (1.4) 34.7 (1.8) 0.99*
SVD, n (%) 107 (54) 13 (37) 0.23†
Day of delivery 0.55†
Month of delivery 0.1†
All data mean (SD) unless otherwise stated.
*t test, Mann-Whitney test.
†χ2 test.























F220 Abernethy C, et al. Arch Dis Child Fetal Neonatal Ed 2018;103:F216–F220. doi:10.1136/archdischild-2016-311686
Original article
ethics approval The study was approved by West of Scotland Ethics Committee 4.
Provenance and peer review Not commissioned; externally peer reviewed.
© Article author(s) (or their employer(s) unless otherwise stated in the text of the 
article) 2018. All rights reserved. No commercial use is permitted unless otherwise 
expressly granted.
RefeRences
 1 Public Health England. National treatment agency for substance abuse. Alcohol 
treatment in England. 2013 http://www. nta. nhs. uk/ uploads/ adult- alcohol- statistics- 
2013-% 2014- commentary. pdf.% 20accessed% 208/ 5/ 16 (accessed 18 Jun 2016).
 2 The Scottish Health Survey. 2014 http://www. gov. scot/ Resource/ 0048/ 00485587. pdf 
(accessed 24 Nov 2016).
 3 http://www. gov. scot/ Topics/ Health/ Services/ Alcohol (accessed 30 Nov 2016).
 4 Department of Health. 2016 https://www. gov. uk/ government/ news/ new- alcohol- 
guidelines- show- increased- risk- of- cancer (accessed 18 Jun 2016).
 5 Anderson AE, Hure AJ, Forder PM, et al. Risky drinking patterns are being continued 
into pregnancy: a prospective cohort study. PLoS One 2014;9:e86171.
 6 BMA Science and Education Department and the Board of Science. Alcohol spectrum 
disorders - a guideline for healthcare professionals. 2016 https://www. bma. org. uk/-/./ 
fetal- alcohol- spectrum- disorders- report- feb2016. pdf (accessed 21 Jun 16).
 7 Mukherjee RA, Hollins S, Turk J. Fetal alcohol spectrum disorder: an overview. J R Soc 
Med 2006;99:298–302.
 8 May PA, Baete A, Russo J, et al. Prevalence and characteristics of fetal alcohol 
spectrum disorders. Pediatrics 2014;134:855–66.
 9 Derauf C, Katz AR, Easa D. Agreement between maternal self-reported ethanol intake 
and tobacco use during pregnancy and meconium assays for fatty acid ethyl esters 
and cotinine. Am J Epidemiol 2003;158:705–9.
 10 Wurst FM, Kelso E, Weinmann W, et al. Measurement of direct ethanol metabolites 
suggests higher rate of alcohol use among pregnant women than found with the 
AUDIT–a pilot study in a population-based sample of swedish women. Am J Obstet 
Gynecol 2008;198:407.e1–5.
 11 Gareri J, Lynn H, Handley M, et al. Prevalence of fetal ethanol exposure in a regional 
population-based sample by meconium analysis of fatty acid ethyl esters. Ther Drug 
Monit 2008;30:239–45.
 12 Himes SK, Dukes KA, Tripp T, et al. Prenatal alcohol in SIDS and stillbirth (PASS) 
Network. clinical sensitivity and specificity of meconium fatty acid ethyl ester, ethyl 
glucuronide, and ethyl sulfate for detecting maternal drinking during pregnancy. Clin 
Chem 2015;61:523–32.
 13 Bakdash A, Burger P, Goecke TW, et al. Quantification of fatty acid ethyl esters (FAEE) 
and ethyl glucuronide (EtG) in meconium from newborns for detection of alcohol 
abuse in a maternal health evaluation study. Anal Bioanal Chem 2010;396:2469–77.
 14 Cabarcos P, Tabernero MJ, Otero JL, et al. Quantification of fatty acid ethyl esters 
(FAEE) and ethyl glucuronide (EtG) in meconium for detection of alcohol abuse 
during pregnancy: correlation study between both biomarkers. J Pharm Biomed Anal 
2014;100:74–8.
 15 Chan D, Bar-Oz B, Pellerin B, et al. Population baseline of meconium fatty acid ethyl 
esters among infants of nondrinking women in Jerusalem and Toronto. Ther Drug 
Monit 2003;25:271–8.
 16 Garcia-Algar O, Kulaga V, Gareri J, et al. Alarming prevalence of fetal alcohol exposure 
in a Mediterranean city. Ther Drug Monit 2008;30:249–54.
 17 Joya X, Friguls B, Ortigosa S, et al. Determination of maternal-fetal biomarkers of 
prenatal exposure to ethanol: a review. J Pharm Biomed Anal 2012;69:209–22.
 18 McGlone L, Mactier H, Hassan H, et al. In utero drug and alcohol exposure in infants 
born to mothers prescribed maintenance methadone. Arch Dis Child Fetal Neonatal 
Ed 2013;98:F542–44.
 19 Vaiano F, Favretto D, Palumbo D, et al. A novel, simultaneous extraction of 
FAEE and EtG from meconium and analysis by LC-MS/MS. Anal Bioanal Chem 
2016;408:2587–94.
 20 Scottish government. http://www. gov. scot/ Publications/ 2006/ 06/ 05104841/ 10 
(accessed 21 Jun 2016).
 21 McQuire C, Paranjothy S, Hurt L, et al. Objective measures of prenatal alcohol 
exposure: a systematic review. Pediatrics 2016;138:e20160517.
 22 Hutson JR, Magri R, Gareri JN, et al. The incidence of prenatal alcohol exposure 
in Montevideo Uruguay as determined by meconium analysis. Ther Drug Monit 
2010;32:311–7.
 23 Pichini S, Pellegrini M, Gareri J, et al. Liquid chromatography-tandem mass 
spectrometry for fatty acid ethyl esters in meconium: assessment of prenatal exposure 
to alcohol in two European cohorts. J Pharm Biomed Anal 2008;48:927–33.
 24 Zelner I, Hutson JR, Kapur BM, et al. False-positive meconium test results for fatty 
acid ethyl esters secondary to delayed sample collection. Alcohol Clin Exp Res 
2012;36:1497–506.






















d: first published as 10.1136/archdischild-2016-311686 on 4 July 2017. D
ow
nloaded from
 
